Pacira BioSciences, Inc. (PCRX) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Pacira Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.075 Good day and thank you for standing by. Welcome to Pacera BioSciences' second 00:00:05.075 -- 00:00:10.399 quarter 2026 earnings conference call. At this time, all participants 00:00:10.399 -- 00:00:15.443 are in a listen-only mode. After the speaker's presentation, there will be a question 00:00:15.443 -- 00:00:20.506 and answer session. To ask a question during the session, you'll need to press star 00:00:20.506 -- 00:00:25.930 1-1 on your telephone. You'll hear an automated message advising your hand is raised. 00:00:25.930 -- 00:00:30.220 To withdraw your question, please press star 1-1 again. 00:00:30.220 -- 00:00:33.862 Please be advised that today's conference is being recorded. 00:00:33.862 -- 00:00:39.144 I would now like to hand the conference over to your first speaker today, Susan Mesco, 00:00:39.144 -- 00:00:43.605 Head of Investor Relations. Please go ahead. 00:00:45.226 -- 00:00:49.668 Thank you. Good afternoon, everyone. Welcome to today's conference call to discuss our 00:00:49.668 -- 00:00:54.990 second quarter of 2026 financial results. Joining me are Frank Lee, 00:00:54.990 -- 00:01:00.360 Chief Executive Officer, Brendan Teehan, Chief Commercial Officer, and Shawn Cross, 00:01:00.360 -- 00:01:05.664 Chief Financial Officer. Kristen Williams, Chief Administrative Officer and Secretary, 00:01:05.664 -- 00:01:10.969 Tony Molloy, Chief Legal Officer and Jonathan Slonin, Chief Medical Officer are also 00:01:10.969 -- 00:01:13.791 here for today's question and answer session. 00:01:13.791 -- 00:01:19.075 Before we begin, let me remind you that this call will include forward-looking statements 00:01:19.075 -- 00:01:23.119 subject to the state partner provisions of federal securities laws. 00:01:23.119 -- 00:01:28.918 ...